A Single-Blind Randomized Controlled Study Comparing the Efficacy of High-Intensity Laser Therapy and Focused Extracorporeal Shock Wave Therapy in Patients With Plantar Fasciitis
Starting soon · Not applicable
Conditions studied: Plantar Fasciitis
In brief
This randomized controlled trial aims to evaluate the efficacy of High-Intensity Laser Therapy (HILT) and Focused Extracorporeal Shock Wave Therapy (fESWT) in reducing pain in patients with plantar fasciitis. The study also examines the effects of HILT and fESWT on health-related outcomes, including VAS-FA, FFI, plantar fascia thickness, and adverse events. Researchers will compare HILT with fESWT as treatment options for patients with plantar fasciitis. Participants will receive either HILT or fESWT along with an exercise program. They will attend follow-up visits to assess outcomes at 1, 2, 3, 6, and 12 weeks after the first treatment.
Key facts
- Study ID
- NCT07287046
- Run by
- Mahidol University
- People needed
- 28
- Starts
- 2026-02-28
- Expected to finish
- 2027-02-20
- Last updated by the study team
- 2026-03-25
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients aged 18-70 years
- Pain was worse in the initial step after and an extended period of rest
- Pain was decreased initially after the first steps but exacerbated with increased activity
- VAS ≥ 4
- Pain was localized and sharp but not radiating,
- Pain was reproduced with palpation of the plantar fascia
You may not qualify if…
- Have Wound/Infection/tumor in treatment area
- History of foot trauma in 3 months
- History of intervention at plantar fascia in 6 months such as Ultrasound therapy, steroid injection, surgery or botulinum toxin injection
- Pain medication within one week before participation
- Patient wasn't desired to participate in the study
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.